![Rajiv Patni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Rajiv Patni is Director at BioXcel Therapeutics, Inc. since 2025 and Chief Medical Officer at Septerna, Inc. since 2026.
Former roles include Chief Executive Officer & Director at Judo Bio, Inc., Executive Director & Vice President at Roche Pharmaceuticals, Inc., Independent Director at Quince Therapeutics, Inc. from 2024 to 2026, Senior Medical Director at Novartis Pharmaceuticals Corp., Senior Medical Director at Pfizer Pharmaceuticals, Inc., Executive VP, Chief Research & Development Officer at Reata Pharmaceuticals, Inc. in 2023, Chief Medical Officer at Adamas Pharmaceuticals LLC from 2015 to 2020, Chief Development Officer at OCERA Therapeutics LLC from 2014 to 2015, Chief Medical Officer at Actelion Pharmaceuticals US, Inc. from 2007 to 2014, Chief Medical Officer & Executive Vice President at Portola Pharmaceuticals LLC in 2020, and Chief Medical Officer at Global Blood Therapeutics, Inc. from 2020 to 2023.
Education includes a doctorate from Icahn School of Medicine at Mount Sinai and an undergraduate degree from The Sophie Davis School of Biomedical Education.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 09/01/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Director/Miembro de la Junta | 15/01/2025 |
| SEPTERNA, INC. | Director Técnico/Científico/I+D | 25/08/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director/Miembro de la Junta | 30/01/2026 |
| REATA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 26/09/2023 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/06/2023 |
| PORTOLA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/07/2020 |
| ADAMAS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 15/02/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 15 |
|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
The Sophie Davis School of Biomedical Education
 The Sophie Davis School of Biomedical Education Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Judo Bio, Inc.
 Judo Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops oligonucleotide medicine | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
